Enabling Precision MedicineNewomics Inc., a biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare.
Our award-winning multinozzle emitter technologies empower mass spectrometry through integration and miniaturization. The microfluidic chip splits incoming flow evenly into multiple smaller streams and hence enhances ionization efficiency significantly to achieve unprecedented robustnessand sensitivity.
Newomics® M3 emitter is the first commercial multinozzle emitter device for mass spectrometry. Our chip is manufactured on silicon using semiconductor microfabrication techniques. The unique chip design with precision-machining method and plug-and-play interface delivers ultimate sensitivity, reliability, simplicity, and ruggedness.
Proprietary platforms and assays enable LC-MS-based proteomics, metabolomics, and lipidomics analyses of small amounts of biological samples, including human plasma and mammalian cells, as well as host cell proteins, CHO cell culture media, and antibody drugs.
May 2, 2016Newomics announces that it has been awarded an NIH SBIR Phase II grant totaling $1.5 million to further develop and commercialize new platforms and solutions for natural products R&D.
May 18, 2017Newomics will launch its first line of product Newomics® M3 emitters and showcase its platforms and solutions with three scientific posters at the 65th ASMS Conference on Mass Spectrometry and Allied Topics, June 4-8, 2017, Indianapolis, IN. Please stop by our Booth 809!
May 17, 2017Newomics will showcase its products and services at the 2017 BIO International Convention, June 19-22, 2017, San Diego, CA. Please stop by our Booth 5607 in the “Innovation Zone”!
April 12, 2017Newomics has signed an exclusive license agreement with The University of California through Lawrence Berkeley National Laboratory to commercialize M3 emitters and MEA chips.
May 15, 2016Newomics has been selected to exhibit and showcase its technologies in the “Innovation Zone” and present in the business forum at the 2016 BIO International Convention in San Francisco, CA (June 6-9, 2016).
